HIF1A and cancer: Guzy and Schumacker [47] specifically addressed this paradox of increased ROS generation during hypoxia, while Semenza’s review [48] highlighted the significance of these HIF-1α-mediated mechanisms in cancer progression and potential therapeutic interventions.